Identification of CD24 as a marker for tumorigenesis of melanoma.

about

Identification of CD24 as a marker for tumorigenesis of melanoma.

Item

http://www.wikidata.org/entity/Q55259421

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Identification of CD24 as a marker for tumorigenesis of melanoma.

@en

Identification of CD24 as a marker for tumorigenesis of melanoma.

@nl

type

Item

label

Identification of CD24 as a marker for tumorigenesis of melanoma.

@en

Identification of CD24 as a marker for tumorigenesis of melanoma.

@nl

prefLabel

Identification of CD24 as a marker for tumorigenesis of melanoma.

@en

Identification of CD24 as a marker for tumorigenesis of melanoma.

@nl

P1476

Identification of CD24 as a marker for tumorigenesis of melanoma.

@en

P2093

Di Wang

http://www.w3.org/2001/XMLSchema#string

Jia-Yan Guo

http://www.w3.org/2001/XMLSchema#string

Ming-Rui Tang

http://www.w3.org/2001/XMLSchema#string

Nan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective identification of tumorigenic breast cancer cells

Notch signaling: its roles and therapeutic potential in hematological malignancies

CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.

β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1.

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts

CD24 expression predicts poor prognosis for patients with cutaneous malignant melanoma.

HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.

Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts.

CD24 negative lung cancer cells, possessing partial cancer stem cell properties, cannot be considered as cancer stem cells.

STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells

P304

3401-3406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S157043

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29928131

http://www.w3.org/2001/XMLSchema#string

P932

6003289

http://www.w3.org/2001/XMLSchema#string